To validate our hypothesis, we examined STING/IFN‐γ expression in cultured Vδ2 γδ T cells from patients with lung cancer and observed significantly lower STING expression in lung cancer patients than in healthy donors (Figure 4A,B). The gene discussed is STING1; the disease is lung carcinoma.